About 2,616 results
FDA Approves BIOTRONIK's Ultrathin Orsiro Stent for the Treatment of Coronary Artery Disease

Feb 21st, 2019 - BIOTRONIK today announced FDA approval of the Orsiro drug-eluting stent (DES) system. Orsiro is the first and only ultrathin DES to outperform the clinical standard, Xience. Orsiro received CE marking in 2011 and has been used to treat more than one million patients worldwide to date. Orsiro's unprecedented clinical performance in the BIOFLOW-V pivotal trial demonstrated significantly lower ra...

AGGRASTAT® (tirofiban hydrochloride) Injection, Solution

AGGRASTAT® is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events.


Maze IV Procedure is an open-heart procedure that uses ablations or energy sources to scar the tissue causing the heart’s rhythm to be disrupted. The Maze IV procedure is done by a cardiothoracic surgeon and is considered the gold standard for treating atrial fibrillation.

BEVYXXA® (betrixaban)

HCPs can find information about Bevyxxa, an oral anticoagulant, here.

EFFIENT® (prasugrel) TABLETS

Effient taken with aspirin can help reduce the risk of a future thrombotic CV-related event, including stent thrombosis, in patients who had an acute coronary syndrome (ACS) event that was treated with angioplasty.


KENGREAL® (cangrelor) is an injection of cangrelor. See benefits & risks.

Norvasc® (amlodipine besylate) Tablets

Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of NORVASC, particularly in patients with severe obstructive ...

PRADAXA® (dabigatran etexilate mesylate) capsules

PRADAXA is the only NOAC with a specific reversal, available in all 50 states. See how PRADAXA compares to warfarin, and find dosing and coverage information. Please see Important Safety Information and full Prescribing Information, including boxed warning.

REPATHA® (evolocumab) injection

Learn about PCSK9 inhibitor Repatha® (evolocumab) and how it reduces risk of stroke and myocardial infarction in your patients with established CV disease.

CORVERT® (ibutilide fumarate)

CORVERT medication page for healthcare professionals to search for scientific information on Pfizer medications. Also find the package insert, announcements, resources, and ways to connect with Pfizer Medical through a variety of channels.

GORE® EXCLUDER® AAA Endoprosthesis

With more than 20 years of experience, the trusted performance of the GORE® EXCLUDER® Device is paired with the intuitive GORE® C3® Delivery System to provide optimal infrarenal seal and reliable results, even in more challenging anatomies.


The third generation of MitraClip allows you to treat your everyday cases and more complex cases with greater ease

MitraClip NT Clip Delivery System and MitraClip NTR/XTR Clip Delivery System - P100009/S028

The MitraClip NT Clip Delivery System and MitraClip NTR/XTR Clip Delivery System are two newer models of the MitraClip Clip Delivery System approved previously by the FDA. Each system contains a permanent implant that looks and functions like a clip. The clip is used to grasp the two leaflets of the mitral valve in the heart and clip them together to reduce the backflow of blood (called mitral ...

MULTAQ® (dronedarone)

Official site for healthcare professionals. MULTAQ is for patients with paroxysmal or persistent atrial fibrillation (AFib) new to rhythm control therapy

RETAVASE® (reteplase)

See the full Prescribing Information for RETAVASE® (reteplase)–available from Chiesi. Find links for clinical trial data, dosing, ordering, and more.

LIPITOR® (atorvastatin calcium)

LIPITOR ® (atorvastatin calcium) tablets are contraindicated in patients with a known hypersensitivity to any component of this product; in patients with active ...

Lovenox® (enoxaparin sodium injection)

Find out more information about LOVENOX and how it may help your patients.

LUCENTIS® (ranibizumab injection)

Find important information about LUCENTIS® (ranibizumab injection) specifically tailored for healthcare professionals here. INDICATIONS LUCENTIS® (ranibizumab injection) is indicated for the treatment of patients with: Neovascular (wet) age-related macular degeneration (wAMD) Macular edema following retinal vein ...

KAPSPARGO SPRINKLE (metoprolol succinate) capsules extended release Prescribing Information

KAPSPARGO Sprinkle is a beta1-selective adrenoceptor blocking agent indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.


Major CV guidelines recommend aspirin as a first-line treatment for secondary prevention of MI and Ischemic Stroke - even above other treatments.